Results 121 to 130 of about 129,956 (312)

COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW

Pakistan Armed Forces Medical Journal, 2020
Objective: To determine the efficacy of intracoronary verapamil vs adenosine in restoration of coronary blood flow, post PCI in patients with No-Reflow. Study Design: Double blind (patient/operator blind) randomized control trial.
Mohsin Saif, Obaid -Ur- Rahman, Muhammad Umar Amin, Hamid Sharif Khan, Ghulam Rasool Maken, Qamar-Uz-Zaman Bhatti, Zohair Aziz, Anam Fatima Janjua, Sohail Aziz   +8 more
doaj   +1 more source

Circulating Biomarkers to Identify Responders in Cardiac Cell therapy. [PDF]

, 2017
Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute myocardial infarction (STEMI) has no biological inclusion criteria. Here, we analyzed 63 biomarkers and cytokines in baseline plasma samples from 77 STEMI patients treated with BM-MNCs ...
Bolli, Roberto, Cauwenberghs, Nicholas, Haddad, Francois, Henry, Timothy D, Hou, Jiayi, Jokerst, Jesse V, Kuznetsova, Tatiana, Moyé, Lem, Pepine, Carl J, Rosenberg-Hasson, Yael, Schulman, Ivonne H, Schutt, Robert, Sweeney, Timothy, Taylor, Doris A, Traverse, Jay H, Yang, Phillip C, Zhao, Eric   +16 more
core  

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

ESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén, Bård Andre Bendiksen, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Gary McGinley, Almira Hasic, Ida Marie Hauge‐Iversen, Hege Katrin Ugland, Xin Shen, Michael Frisk, Nishani S. Mabotuwana, William E. Louch, Rizwan I. Hussain, Lili Zhang, Ivar Sjaastad, Alessandro Cataliotti, Geir Christensen   +16 more
wiley   +1 more source

Critical Appraisal of Medical System Performance for STEMI Management – a Comprehensive Analysis of Time Efficiency

Journal of Cardiovascular Emergencies
Time intervals related to ST-segment myocardial infarction (STEMI) revascularization are central determinants for patient outcomes. The current capability of the Romanian STEMI program to meet guideline-recommended time intervals is largely unknown.
Dumitraşcu Silviu, Cîrjan Alexandru, Bartoş Daniela, Chioncel Ovidiu, Ştefan Mihai, Deleanu Dan   +5 more
doaj   +1 more source

Thrombolysis during Cardiopulmonary Resuscitation in Cardiac Arrest Secondary to Acute Coronary Syndrome: Four-Case Series. [PDF]

Batna Journal of Medical Sciences
Background: Cardiac arrest (CA) secondary to acute coronary syndrome, particularly ST-elevation myocardial infarction (STEMI), is associated with high mortality.
Fadela AOUNE, Fouzia BELABES, Nesrine TEBIB, Amina KHOULKHLAL, Afaf BENKHEMKHEM   +4 more
doaj   +1 more source

Spontaneous Coronary Artery Dissection: A Case Series of 9 Patients With Literature Review. [PDF]

, 2018
Spontaneous coronary artery dissection is an increasingly recognized nonatherosclerotic cause of acute coronary syndrome. Reports regarding the prognosis and natural history of this disease are limited.
Ali, Nouman Safdar, Anjum, Reema, Ghani, MD, Ali Raza, Hashmi, Arsalan Talib, Inayat, Faisal, Klugherz, Bruce D., Riaz, Iqra, Viray, Michael, Virk, Hafeez Ul Hassan   +8 more
core   +2 more sources

Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock

Catheterization and cardiovascular interventions, 2020
Bleeding complications and acute limb ischemia (ALI) are devastating vascular complications in patients with ST‐segment elevation myocardial infarction (STEMI). Cardiogenic shock (CS) can further increase this risk due to multiorgan failure.
M. Pahuja, S. Ranka, O. Chehab, Tushar Mishra, E. Akintoye, O. Adegbala, A. Yassin, T. Ando, K. Thayer, P. Shah, C. Kimmelstiel, P. Salehi, N. Kapur   +12 more
semanticscholar   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source